Macrophage cell lines derived from major histocompatibility complex II-negative mice

  • Alison A. Beharka
  • Jason W. Armstrong
  • Stephen K. Chapes


Two bone-marrow-derived macrophage cell lines, C2D and C2Dt, were isolated from major histocompatibility class II-negative knock-out mice. The C2D cell line was stabilized by continuous culture in colony-stimulating factor-1 and the C2Dt cell line was transformed with SV40 virus large T antigen. These cells exhibited phenotypic properties of macrophages including morphology and expression of Mac 1 and Mac 2 cell surface molecules. These cells also had comparable growth to the bone-marrow-derived macrophage cell line B6MP102. These new cell lines were not spontaneously cytotoxic and were only capable of modest killing of F5b tumor cells when stimulated with LPS and interferon-γ, but not when stimulated with LPS alone or with staphylococcal exotoxin. C2D and C2Dt cells phagocytosed labeled Staphylococcus aureus similarly to B6MP102 cells but less well than C2D peritoneal macrophages. These cell lines secreted interleukin-6, but not tumor necrosis factor or nitric oxide in response to LPS or staphylococcal enterotoxins A or B. C2Dt cells were tumorigenic in C2D and C57BL/6J mice but C2D cells were not. These data suggest that macrophage cell lines can be established from bone marrow cells of major histocompatibility complex II-negative mice.

Key words

bone-marrow-derived macrophages major histocompatibility class II staphylococcal exotoxins 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adami, C.: Brunda, M.; Palleroni, A. In vivo immortalization of murine peritoneal macrophages: a new rapid and efficient method for obtaining macrophage cell lines. J. Leukocyte Biol. 53:475–478; 1993.PubMedGoogle Scholar
  2. 2.
    Armstrong, J. A.; Nelson, K.; Simske, S., et al. Skeletal unloading causes organ specific changes in immune cell responses. J. Appl. Physiol. 75:2734–2739; 1993.PubMedGoogle Scholar
  3. 3.
    Armstrong, J. A.; Simske, S.; Beharka, A. A., et al. Class I and class II major histocompatibility (MHC) molecules play a role in bone marrow-derived macrophage development. J. Leukocyte Biol. 55:658–661; 1994.PubMedGoogle Scholar
  4. 4.
    Beharka, A. A.; Armstrong, J.; Iandolo, J. J., et al. Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins. Infect. Immun. 62:3907–3915; 1994.PubMedGoogle Scholar
  5. 5.
    Beharka, A.; Iandolo, J.; Chapes, S. Staphylococcal enterotoxins bind H-2Db molecules on macrophages. Proc. Natl. Acad. Sci. USA 92:6294–6298; 1995.PubMedCrossRefGoogle Scholar
  6. 6.
    Bohmer, R.; Trinkle, I.; Staneck, J. Dose effects of LPS on neutrophils in a whole blood flow cytometry assay of phagocytosis and oxidative burst. Cytometry 13:525–531; 1992.PubMedCrossRefGoogle Scholar
  7. 7.
    Cantor, H.; Crump, A.; Raman, V., et al. Immunoregulatory effect of superantigens: interactions of staphylococcal enterotoxins with host MHC and non MHC products. Immunol. Rev. 131:27–42; 1993.PubMedCrossRefGoogle Scholar
  8. 8.
    Chapes, S. K.; Beharka, A.; Hart, M., et al. Differential RNA regulation by staphylococcal enterotoxins A and B in murine macrophages. J. Leukocyte Biol. 55:523–529; 1994.PubMedGoogle Scholar
  9. 9.
    Chapes, S. K.; Didier, E.; Tompkins, W. A. F. Macrophage cell line B6MP102 resembles peritoneal macrophages in tumor cell recognition and killing. J. Leukocyte Biol. 43:28–35; 1988.PubMedGoogle Scholar
  10. 10.
    Chapes, S. K.; Duffin, D.; Paulsen, A. Characterization of macrophage recognition and killing of SV40-transformed tumor cells that are “resistant” or “susceptible” to contact-mediated killing. J. Immunol. 140:589–596; 1988.PubMedGoogle Scholar
  11. 11.
    Chapes, S. K.; Gooding, L. R. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors. J. Immunol. 135:2192–2198; 1985.PubMedGoogle Scholar
  12. 12.
    Chapes, S.; Morrison, D.; Guikema, J., et al. Cytokine secretion by immune cells in space. J. Leukocyte Biol. 52:104–110; 1992.PubMedGoogle Scholar
  13. 13.
    Chapes, S. K.; O’Neil, A.; Flaherty, L., et al. Macrophage-resistant murine simian virus 40 tumors express a retroviral type-specific gp70. J. Virol. 61:928–932; 1987.PubMedGoogle Scholar
  14. 14.
    Flebbe, L.; Chapes, S. K.; Morrison, D. R. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations: differential effects of IFN-γ. J. Immunol. 145:1505–1511; 1990.PubMedGoogle Scholar
  15. 15.
    Fleming, S. D.; Iandolo, J. J.; Chapes, S. K. Murine macrophage activation by staphylococcal exotoxins. Infect. Immun. 59:4049–4055; 1991.PubMedGoogle Scholar
  16. 16.
    Gooding, L. R.; Geib, R.; O’Connell, K., et al. Antibody and cellular detection of SV40 T-antigenic determinants on the surfaces of transformed cells. In, Levine, A. J.; Van de Woude, G.; Topp, W. C. et al., Cancer Cells. 1. The transformed phenotype. Cold Springs Harbor. NY. 1994:263–270.Google Scholar
  17. 17.
    Graham, F.; van der Eb, A. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467; 1973.PubMedCrossRefGoogle Scholar
  18. 18.
    Grusby, M.; Glimcher, L. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13:417–435; 1995.PubMedCrossRefGoogle Scholar
  19. 19.
    Grusby, M.; Johnson, R.; Papaioannou, V., et al. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 253:1417–1420; 1991.PubMedCrossRefGoogle Scholar
  20. 20.
    Helle, M.; Boeije, L.; Aarden, L. Functional discrimination between interleukin 6 and interleukin 1. Eur. J. Immunol. 18:1535–1540; 1988.PubMedCrossRefGoogle Scholar
  21. 21.
    Ho, M. K.; Springer, T. MAC-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J. Immunol. 128:1221–1228; 1982.PubMedGoogle Scholar
  22. 22.
    Jardetzky, T.; Brown, J.; Gorga, J., et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with super-antigen. Nature. 368:711–718; 1994.PubMedCrossRefGoogle Scholar
  23. 23.
    Jat, P.; Sharp, P. Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature. Mol. Cell. Biol. 9:1672–1681; 1989.PubMedGoogle Scholar
  24. 24.
    Johnson, C.; Kitz, D.; Little, J. A method for the derivation and continuous propagation of cloned murine bone marrow macrophages. J. Immunol. Methods 65:319–332; 1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Kopydlowski, K.; McVey, D.; Woods, K., et al. Effects of antiorthostatic suspension and corticosterone on macrophage and spleen cell function. J. Leukocyte Biol. 52:202–208; 1992.PubMedGoogle Scholar
  26. 26.
    Koren, H.; Handwerger, B.; Wunderlich, J. Identification of macrophage-like characteristics in a cultured murine tumor line. J. Immunol. 114:894; 1975.PubMedGoogle Scholar
  27. 27.
    Leenen, J.; Jansen, A.; van Ewijk, W. Murine macrophage cell lines can be ordered in a linear differentiation sequence. Differentiation 32:157–164; 1986.PubMedCrossRefGoogle Scholar
  28. 28.
    Lombard, Y.; Bartholeyns, J.; Chokri, M. I. D., et al. Establishment and characterization of long-term cultured cell lines of murine resident macrophages. J. Leukocyte Biol. 44:391–401; 1988.PubMedGoogle Scholar
  29. 29.
    Macmillan, E.; Gonda, T. Murine myeloid cells transformed by myb require fibroblast-derived or autocrine growth factors in addition to granulocyte-macrophage colony-stimulating factor for proliferation. Blood 83:209–216; 1994.PubMedGoogle Scholar
  30. 30.
    Oi, V.; Herzenberg, L. Selected methods in cellular immunology. In: Mishell, B.; Shiigi, S. M., eds. Selected methods in cellular immunology. San Francisco, CA: W. H. Freeman; 1980.Google Scholar
  31. 31.
    Ralph, P. Continuous macrophage cell lines—their use in the study of induced and constitutive macrophage properties and cytotoxicity. Lymphokines 4:175–195; 1981.Google Scholar
  32. 32.
    Ralph, P. Continuous cell lines with properties of mononuclear phagocytes. In, Herscowitz, H. B.; Holden, H. T.; Bellanti, J. A. et al. Methods for studying mononuclear phagocytes. Academic Press, New York, NY. 1981 pp. 155–173.Google Scholar
  33. 33.
    Ralph, P.; Nakoinz, I. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines. Cancer Res. 41:3546–3550; 1981.PubMedGoogle Scholar
  34. 34.
    Raschke, W.; Baird, S.; Ralph, P., et al. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261–265; 1978.PubMedCrossRefGoogle Scholar
  35. 35.
    Rosenkrans, C., Jr.; Chapes, S. Macrophage binding of cells resistant and sensitive to contact-dependent cytotoxicity. Cell. Immunol. 133:187–195; 1991.PubMedCrossRefGoogle Scholar
  36. 36.
    Serreze, D.; Gaedeke, J.; Leiter, E. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. USA 90:9625–9629; 1993.PubMedCrossRefGoogle Scholar
  37. 37.
    Serreze, D.; Gaskins, H.; Leiter, E. Defects in the differentiation and function of antigen presenting cells in Nod/Lt mice. J. Immunol. 150:2534–2543; 1993.PubMedGoogle Scholar
  38. 38.
    Southern, P. J.; Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327–341; 1982.PubMedGoogle Scholar
  39. 39.
    Stuehr, D.; Nathan, C. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543–1555; 1989.PubMedCrossRefGoogle Scholar
  40. 40.
    Taniyama, T.; Holden, H. Cytolytic activity against tumor cells by macrophage cell lines and augmentation by macrophage stimulants. Int. J. Cancer 26:61–69; 1980.PubMedCrossRefGoogle Scholar
  41. 41.
    Woods, K. M.; Chapes, S. K. Three distinct cell phenotypes of induced-TNF cytotoxicity and their relationship to apoptosis. J. Leukocyte Biol. 53:37–44; 1993.PubMedGoogle Scholar
  42. 42.
    Wynn, T.; Freund, Y.; Paulnock, D. TNF-alpha differentially regulates Ia andigen expression and macrophage tumoricidal activity in two murine macrophage cell lines. Cell. Immunol. 140:184–196; 1992.PubMedCrossRefGoogle Scholar
  43. 43.
    Zarling, J.; Tevethia, S. Transplantation immunity to Simian Virus 40-transformed cells in tumor bearing mice. I. Development of cellular immunity to SV40 tumor specific transplantation antigens during tumorigenesis by transplanted cells. J. Natl. Cancer Inst. 50:137–157; 1973.PubMedGoogle Scholar

Copyright information

© Society for In Vitro Biology 1998

Authors and Affiliations

  • Alison A. Beharka
    • 1
  • Jason W. Armstrong
    • 1
  • Stephen K. Chapes
    • 1
  1. 1.Division of BiologyKansas State UniversityManhattan

Personalised recommendations